Anti-IL5/IL5R Treatment in COPD: Should We Target Oral Corticosteroid-Dependent Patients?

Anti-IL5/IL5R Treatment in COPD: Should We Target Oral Corticosteroid-Dependent Patients?

Jérémy Laroche,1 Geneviève Pelletier,1 Marie-Ève Boulay,1 Andréanne Côté,1,2 Krystelle Godbout1,2 1Department of Pulmonology and Thoracic Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada; 2Department of Medicine, Faculty of Medicine, Laval University, Quebec City,...

Full description

Bibliographic Details
Main Authors: Laroche J, Pelletier G, Boulay M, Côté A, Godbout K
Format: Article
Language:English
Published: Dove Medical Press 2023-05-01
Series:International Journal of COPD
Subjects:
copd
treatment
anti-il5
monoclonal antibodies
exacerbations
oral corticosteroids.
Online Access:https://www.dovepress.com/anti-il5il5r-treatment-in-copd-should-we-target-oral-corticosteroid-de-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/anti-il5il5r-treatment-in-copd-should-we-target-oral-corticosteroid-de-peer-reviewed-fulltext-article-COPD

Similar Items